Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EU63 | ISIN: US89853L3024 | Ticker-Symbol: 3T2
Stuttgart
27.06.25 | 08:03
0,094 Euro
+0,21 % +0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
T2 BIOSYSTEMS INC Chart 1 Jahr
5-Tage-Chart
T2 BIOSYSTEMS INC 5-Tage-Chart

Aktuelle News zur T2 BIOSYSTEMS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
01.04.T2 Biosystems, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT40534
20.02.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.02.2025724The following instruments on Boerse Frankfurt do have their last trading day on 20.02.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.02.2025.ISIN NameCA24703H1029 DELIVRA...
► Artikel lesen
20.02.T2 Biosystems, Inc. - 8-K, Current Report29
11.02.T2 Biosystems, Inc. - 8-K, Current Report51
17.01.T2 Biosystems, Inc. - 8-K, Current Report17
T2 BIOSYSTEMS Aktie jetzt für 0€ handeln
07.01.T2 Biosystems Reports Preliminary Financial Results For Q4 And Full Year 202420
07.01.T2 Biosystems reports preliminary Q4 product revenues of $2.3M6
03.01.T2 Biosystems, Inc. - 8-K, Current Report17
16.12.24T2 Biosystems, Inc.: T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.289LEXINGTON, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
► Artikel lesen
07.10.24T2 Biosystems To Sell Its FDA-Cleared Blood Diagnostics For Detection Of Sepsis-Causing Pathogens541WASHINGTON (dpa-AFX) - T2 Biosystems, Inc. (TTOO) Monday said it has reached a multi-year exclusive U.S. agreement with Cardinal Health (CAH) to sell its FDA-cleared direct-from-blood diagnostics...
► Artikel lesen
07.10.24T2 Biosystems, Inc.: T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens214LEXINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the "Company"), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes...
► Artikel lesen
07.10.24T2 Biosystems, Inc.: T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results257LEXINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
► Artikel lesen
20.09.24T2 Biosystems, Inc.: T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union288LEXINGTON, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the "Company"), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes...
► Artikel lesen
29.07.24T2 Biosystems, Inc.: T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor286LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1